NeOnc Technologies Holdings, Inc. (NTHI)Healthcare | Biotechnology | Calabasas, United States | NasdaqGM
4.69 USD
+0.09
(1.846%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 4.69 |
Hot Take ↕ | Aug. 22, 2026, 4:49 a.m. EDT
The immediate outlook is clouded by severe technical weakness and a lack of catalysts. While insider buying provides a glimmer of confidence, the stock is trading significantly below its 200-day average, indicating persistent selling pressure that outweighs recent minor bounces. The statistical forecast model offers no directional guidance due to extremely low reliability, leaving the short-term path undefined rather than clearly bullish. From a long-term perspective, the investment case is fundamentally broken. The company exhibits classic signs of a distressed biotech firm with no revenue, massive losses, and a negative book value. The market has already priced in a catastrophic failure, evidenced by the extreme valuation multiples and the complete absence of a multi-year price appreciation trend. Without a proven product pipeline or a sustainable business model, the equity represents a permanent loss of capital rather than a turnaround opportunity. Finally, there is no dividend component to consider. The company is burning through cash reserves to fund clinical trials and operations, making any distribution of income impossible and inappropriate at this stage. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.118066 |
| AutoARIMA | 0.130884 |
| AutoETS | 0.130887 |
| AutoTheta | 0.131104 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 27% |
| H-stat | 17.61 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.127 |
| Excess Kurtosis | -1.28 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.002 |
| Market Cap | 121,641,552 |
| Forward P/E | -4.66 |
| Website | https://www.neonc.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.3495763 |
| Address1 | 23,975 Park Sorrento |
| Address2 | Suite 205 |
| All Time High | 25.0 |
| All Time Low | 3.005 |
| Ask | 3.57 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 269,750 |
| Average Daily Volume3 Month | 152,711 |
| Average Volume | 152,711 |
| Average Volume10Days | 269,750 |
| Bid | 3.41 |
| Bid Size | 1 |
| Book Value | -0.872 |
| City | Calabasas |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.69 |
| Current Ratio | 0.178 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 4.74 |
| Day Low | 4.51 |
| Display Name | NeOnc |
| Earnings Timestamp | 1,786,365,000 |
| Earnings Timestamp End | 1,794,486,600 |
| Earnings Timestamp Start | 1,794,486,600 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 2,952.421 |
| Enterprise Value | 118,067,296 |
| Eps Current Year | -1.35 |
| Eps Forward | -1.00667 |
| Eps Trailing Twelve Months | -2.17 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.1206 |
| Fifty Day Average Change | 0.56939983 |
| Fifty Day Average Change Percent | 0.13818371 |
| Fifty Two Week Change Percent | -34.95763 |
| Fifty Two Week High | 12.99 |
| Fifty Two Week High Change | -8.299999 |
| Fifty Two Week High Change Percent | -0.638953 |
| Fifty Two Week Low | 3.005 |
| Fifty Two Week Low Change | 1.685 |
| Fifty Two Week Low Change Percent | 0.56073207 |
| Fifty Two Week Range | 3.005 - 12.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,742,995,800,000 |
| Float Shares | 8,076,479 |
| Forward Eps | -1.00667 |
| Forward P E | -4.658925 |
| Free Cashflow | 5,401,299 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 5 |
| Fullday Change | 0.085 |
| Fullday Change Percent | 1.84582 |
| Fullday Price | 4.69 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 39,990 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.58905 |
| Held Percent Institutions | 0.12198 |
| Implied Shares Outstanding | 25,936,365 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-03-26 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California. |
| Long Name | NeOnc Technologies Holdings, Inc. |
| Market | us_market |
| Market Cap | 121,641,552 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1847121177 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -47,200,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 118,529,188 |
| Number Of Analyst Opinions | 3 |
| Open | 4.57 |
| Operating Cashflow | -21,156,676 |
| Operating Margins | -1,044.189 |
| Payout Ratio | 0.0 |
| Phone | 310 663 7831 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 4.69 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 4.605 |
| Price Eps Current Year | -3.4740741 |
| Price Hint | 4 |
| Price To Book | -5.3784404 |
| Price To Sales Trailing12 Months | 3,041.7993 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.09 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.085 |
| Regular Market Change Percent | 1.84582 |
| Regular Market Day High | 4.74 |
| Regular Market Day Low | 4.51 |
| Regular Market Day Range | 4.51 - 4.74 |
| Regular Market Open | 4.57 |
| Regular Market Previous Close | 4.605 |
| Regular Market Price | 4.69 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 100,570 |
| Return On Assets | -6.3499403 |
| Revenue Per Share | 0.002 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 25,936,365 |
| Shares Percent Shares Out | 0.023 |
| Shares Short | 597,816 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 521,841 |
| Short Name | NeOnc Technologies Holdings, In |
| Short Percent Of Float | 0.0551 |
| Short Ratio | 3.14 |
| Source Interval | 15 |
| State | CA |
| Symbol | NTHI |
| Target High Price | 20.0 |
| Target Low Price | 13.0 |
| Target Mean Price | 16.0 |
| Target Median Price | 15.0 |
| Total Cash | 1,973,420 |
| Total Cash Per Share | 0.079 |
| Total Debt | 328,217 |
| Total Revenue | 39,990 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.17 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.6862 |
| Two Hundred Day Average Change | -1.9962001 |
| Two Hundred Day Average Change Percent | -0.29855523 |
| Type Disp | Equity |
| Volume | 100,570 |
| Website | https://www.neonc.com |
| Zip | 91,302 |